Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Dominique Breilh, Jeannette Texier-Maugein, Bernard Allaouchiche, Marie-Claude Saux & Emmanuel Boselli. (2013) Carbapenems. Journal of Chemotherapy 25:1, pages 1-17.
Read now
Read now
Mary L Townsend, Melanie W Pound & Richard H Drew. (2007) Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Therapeutics and Clinical Risk Management 3:6, pages 1059-1070.
Read now
Read now
Ioannis P Kioumis, Joseph L Kuti & David P Nicolau. (2007) Intra-abdominal infections: considerations for the use of the carbapenems. Expert Opinion on Pharmacotherapy 8:2, pages 167-182.
Read now
Read now
S. Colizza & S. Rossi. (2001) Antibiotic Prophylaxis and Treatment of Surgical Abdominal Sepsis. Journal of Chemotherapy 13:sup4, pages 193-201.
Read now
Read now
Ceyda Karadeniz, Aynur Oguz, Berna Canter & Ayse Serdaroglu. (2000) INCIDENCE OF SEIZURES IN PEDIATRIC CANCER PATIENTS TREATED WITH IMIPENEM/CILASTATIN. Pediatric Hematology and Oncology 17:7, pages 585-590.
Read now
Read now
Articles from other publishers (26)
Rui Meng, Xin Guan, Lei Sun, Zhengyang Fei, Yuxin Li, Mengjie Luo, Aixia Ma & Hongchao Li. (2022) The efficacy and safety of eravacycline compared with current clinically common antibiotics in the treatment of adults with complicated intra-abdominal infections: A Bayesian network meta-analysis. Frontiers in Medicine 9.
Crossref
Crossref
Xiuwen Wu, Jie Wu, Peige Wang, Xueling Fang, Yunsong Yu, Jianguo Tang, Yonghong Xiao, Minggui Wang, Shikuan Li, Yun Zhang, Bijie Hu, Tao Ma, Qiang Li, Zhiming Wang, Anhua Wu, Chang Liu, Menghua Dai, Xiaochun Ma, Huimin Yi, Yan Kang, Daorong Wang, Gang Han, Ping Zhang, Jianzhong Wang, Yufeng Yuan, Dong Wang, Jian Wang, Zheng Zhou, Zeqiang Ren, Yuxiu Liu, Xiangdong Guan & Jianan Ren. (2020) Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons. Clinical Infectious Diseases 71:Supplement_4, pages S337-S362.
Crossref
Crossref
Katerina Tori, Giannoula S. Tansarli, Diane M. Parente, Markos Kalligeros, Panayiotis D. Ziakas & Eleftherios Mylonakis. (2020) The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients. Medicine 99:20, pages e20022.
Crossref
Crossref
Lingyuan Chen, Xueyan Liang, Junsong Jiang, Xianshu Li & Yan Li. (2019) Carbapenems vs tigecycline for the treatment of complicated intra-abdominal infections. Medicine 98:40, pages e17436.
Crossref
Crossref
Joan P. Cannon, Todd A. Lee, Nina M. Clark, Paul Setlak & Shellee A. Grim. (2014) The risk of seizures among the carbapenems: a meta-analysis. Journal of Antimicrobial Chemotherapy 69:8, pages 2043-2055.
Crossref
Crossref
Kemal Turkyilmaz, Ali Kurt, Aziz R. Dilek, Berrak Sekeryapan & Ayse Erturk. (2012) A case of suture-related bacterial keratitis and its treatment with topical imipenem. Journal of Ocular Biology, Diseases, and Informatics 4:4, pages 141-144.
Crossref
Crossref
John F. Mohr III. (2008) Update on the Efficacy and Tolerability of Meropenem in the Treatment of Serious Bacterial Infections. Clinical Infectious Diseases 47:s1, pages S41-S51.
Crossref
Crossref
P. Kujath, M. Hoffmann & A. Rodloff. (2008) Antibiotika- und Pilztherapie bei intraabdominellen InfektionenAntimicrobial and antimycotic therapy of intra-abdominal infections. Der Chirurg 79:4, pages 295-305.
Crossref
Crossref
Antonio Basoli, Piero Chirletti, Ercole Cirino, Nicola G. D’Ovidio, Giovanni Battista Doglietto, Domenico Giglio, Stefano M. Giulini, Alberto Malizia, Mario Taffurelli, Jelena Petrovic & Maurizio Ecari. (2007) A Prospective, Double-Blind, Multicenter, Randomized Trial Comparing Ertapenem 3 Vs ≥5 Days in Community-Acquired Intraabdominal Infection. Journal of Gastrointestinal Surgery 12:3, pages 592-600.
Crossref
Crossref
M.-C. Monteiro, A. Danielou, Y. Piemont, Y. Hansmann & S. Rohr. (2007) Prélèvements microbiologiques et traitements antibiotiques probabilistes des péritonites secondaires communautaires. Journal de Chirurgie 144:6, pages 486-491.
Crossref
Crossref
T. L. Husted, E. W. Mueller, T. M. Lasky, M. A. Jafri & J. S. Solomkin. 2007. Infectious Diseases in Critical Care. Infectious Diseases in Critical Care
494
508
.
Steven J. Edwards, Helen E. Campbell & Jonathan M. Plumb. (2006) Cost-utility analysis comparing meropenem with imipenem plus cilastatin in the treatment of severe infections in intensive care. The European Journal of Health Economics 7:1, pages 72-78.
Crossref
Crossref
Jose M. TelladoSamuel E. Wilson. (2005) Empiric Treatment of Nosocomial Intra-Abdominal Infections: A Focus on the Carbapenems. Surgical Infections 6:3, pages 329-343.
Crossref
Crossref
Peng F Wong, Andrew D Gilliam, Senthil Kumar, Jonathan Shenfine, Graham N O'Dair & David J Leaper. (2005) Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Peter Fomin, Mircea Beuran, Audrius Gradauskas, Giedrius Barauskas, Alexey Datsenko, Nathalie Dartois, Evelyn Ellis-Grosse & Evan Loh. (2005) Tigecycline is efficacious in the treatment of complicated intra-abdominal infections. International Journal of Surgery 3:1, pages 35-47.
Crossref
Crossref
Joseph S. Solomkin, John E. Mazuski, Ellen J. Baron, Robert G. Sawyer, Avery B. Nathens, Joseph T. DiPiro, Timothy Buchman, E. Patchen Dellinger, John Jernigan, Sherwood Gorbach, Anthony W. Chow & John Bartlett. (2003) Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections. Clinical Infectious Diseases 37:8, pages 997-1005.
Crossref
Crossref
John E. Mazuski, Robert G. Sawyer, Avery B. Nathens, Joseph T. DiPiro, Moshe Schein, Kenneth A. Kudsk & Charles Yowler. (2002) The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: Evidence for the Recommendations. Surgical Infections 3:3, pages 175-233.
Crossref
Crossref
John E. Mazuski, Robert G. Sawyer, Avery B. Nathens, Joseph T. DiPiro, Moshe Schein, Kenneth A. Kudsk & Charles Yowler. (2002) The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: An Executive Summary. Surgical Infections 3:3, pages 161-173.
Crossref
Crossref
Per Sandven, Hanne Qvist, Eva Skovlund & Karl E. Giercksky. (2002) Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Critical Care Medicine 30:3, pages 541-547.
Crossref
Crossref
Eva Susanne Dietrich, Bj??rn Schubert, Winfried Ebner & Franz Daschner. (2001) Cost Efficacy of Tazobactam/Piperacillin versus Imipenem/Cilastatin in the Treatment of Intra-Abdominal Infection. PharmacoEconomics 19:1, pages 79-94.
Crossref
Crossref
Matthew N. Lowe & Harriet M. Lamb. (2000) Meropenem. Drugs 60:3, pages 619-646.
Crossref
Crossref
Lenore E. Asbel & Matthew E. Levison. (2000) CEPHALOSPORINS, CARBAPENEMS, AND MONOBACTAMS. Infectious Disease Clinics of North America 14:2, pages 435-447.
Crossref
Crossref
Giorgio Zanetti, Stephan Jürgen Harbarth, Andrej Trampuz, Marcus Ganeo, François Mosimann, Roland Chautemps, Pierre Morel, Daniel Lew, Werner Zimmerli, Jochen Lange & Michel Glauser. (1999) Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections. International Journal of Antimicrobial Agents 11:2, pages 107-113.
Crossref
Crossref
Toni Darville. (1999) Imipenem and meropenem. Seminars in Pediatric Infectious Diseases 10:1, pages 38-44.
Crossref
Crossref
Barry Sieger. (1998) Comparisons of Seizure Incidence and Adverse Experiences Between Imipenem and Meropenem. Critical Care Medicine 26:8, pages 1465-1466.
Crossref
Crossref
Jennifer Schranz. (1998) Comparisons of Seizure Incidence and Adverse Experiences Between Imipenem and Meropenem. Critical Care Medicine 26:8, pages 1464-1465.
Crossref
Crossref